Dashboard
Financial statements
IQV

Company financials

IQVIA

Health Care Life Sciences Tools & Services Durham, North Carolina Last filing Feb 17, 2026 · FY2025
Revenue FY2025
$16.3B
Net income FY2025
$1.4B

Balance Sheet

Assets, liabilities, and equity

30 accounts · 5 years
Account 2025 2024 2023 2022 2021
Statement
BS Assets Cash $2.0B $1.7B $1.4B $1.2B $1.4B
BS Assets Accts Receivable $3.4B $3.2B $3.4B $2.9B $2.6B
BS Assets Prepaid Expenses $162.0M $154.0M $141.0M $151.0M $156.0M
BS Assets Total Current $6.2B $5.8B $5.6B $5.0B $4.8B
BS Assets PPE $533.0M $535.0M $523.0M $532.0M $497.0M
BS Assets Op Lease ROU $290.0M $238.0M $296.0M $331.0M $406.0M
BS Assets Goodwill $16.6B $14.7B $14.6B $13.9B $13.3B
BS Assets Intangible Assets $5.0B $4.5B $4.8B $4.8B $4.9B
BS Assets LT Investments $324.0M $266.0M $134.0M $94.0M $88.0M
BS Assets Deferred Tax Assets $357.0M $194.0M $166.0M $118.0M $124.0M
BS Assets Total $29.9B $26.9B $26.7B $25.3B $24.7B
BS Liab Accrued Liab $3.8B $2.9B $2.9B $2.7B $2.4B
BS Liab Deferred Rev Current $2.1B $1.8B $1.8B $1.8B $1.8B
BS Liab Current Debt $1.8B $1.1B $718.0M $152.0M $91.0M
BS Liab Op Lease Current $225.0M $173.0M $223.0M $264.0M $313.0M
BS Liab Other Current $489.0M $193.0M $294.0M $152.0M $207.0M
BS Liab Total Current $8.3B $7.0B $6.5B $5.6B $5.2B
BS Liab Long Term Debt $13.9B $12.8B $13.0B $12.6B $12.0B
BS Liab Op Lease Noncurrent $225.0M $173.0M $223.0M $264.0M $313.0M
BS Liab Deferred Tax Liab $179.0M $196.0M $202.0M $464.0M $410.0M
BS Liab Other Noncurrent $688.0M $668.0M $698.0M $671.0M $649.0M
BS Liab Total $23.3B $20.8B $20.6B $19.6B $18.6B
BS Equity Preferred Stock $0 $0 $0 $0 $0
BS Equity Common Stock $828.7M $834.3M $838.7M $842.1M $846.4M
BS Equity Retained Earnings $7.4B $6.1B $4.7B $3.3B $2.2B
BS Equity Treasury Stock $11.4B $10.1B $8.7B $7.7B $6.6B
BS Equity AOCI $-943.0M $-1.0B $-867.0M $-727.0M $-406.0M
BS Equity NCI $127.0M
BS Equity Total $6.5B $6.1B $6.1B $5.8B $6.0B
BS Equity Total Liab and Equity $29.9B $26.9B $26.7B $25.3B $24.7B